GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Physical Therapy Inc (NYSE:USPH) » Definitions » Operating Income

US Physical Therapy (US Physical Therapy) Operating Income

: $70.0 Mil (TTM As of Dec. 2023)
View and export this data going back to 1992. Start your Free Trial

US Physical Therapy's Operating Income for the three months ended in Dec. 2023 was $16.6 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was $70.0 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. US Physical Therapy's Operating Income for the three months ended in Dec. 2023 was $16.6 Mil. US Physical Therapy's Revenue for the three months ended in Dec. 2023 was $154.8 Mil. Therefore, US Physical Therapy's Operating Margin % for the quarter that ended in Dec. 2023 was 10.73%.

Warning Sign:

US Physical Therapy Inc operating margin has been in a 5-year decline. The average rate of decline per year is -3.4%.

US Physical Therapy's 5-Year average Growth Rate for Operating Margin % was -3.40% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. US Physical Therapy's annualized ROC % for the quarter that ended in Dec. 2023 was -99.44%. US Physical Therapy's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 5.61%.


US Physical Therapy Operating Income Historical Data

The historical data trend for US Physical Therapy's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Physical Therapy Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Income
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 67.43 65.91 75.25 65.91 70.02

US Physical Therapy Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.91 17.47 20.06 15.88 16.62

US Physical Therapy Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $70.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


US Physical Therapy  (NYSE:USPH) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

US Physical Therapy's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=66.46 * ( 1 - 1319.81% )/( (823.688 + 806.806)/ 2 )
=-810.685726/815.247
=-99.44 %

where

Invested Capital(Q: Sep. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1010.186 - 40.355 - ( 147.685 - max(0, 82.356 - 228.499+147.685))
=823.688

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=997.238 - 59.242 - ( 152.825 - max(0, 102.185 - 233.375+152.825))
=806.806

Note: The Operating Income data used here is four times the quarterly (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

US Physical Therapy's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=8.464/( ( (128.733 + max(21.99, 0)) + (129.533 + max(21.308, 0)) )/ 2 )
=8.464/( ( 150.723 + 150.841 )/ 2 )
=8.464/150.782
=5.61 %

where Working Capital is:

Working Capital(Q: Sep. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(52.958 + 0 + 9.387) - (40.355 + 0 + 0)
=21.99

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(69.72 + 0 + 10.83) - (59.242 + 0 + 0)
=21.308

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

3. Operating Income is also linked to Operating Margin %:

US Physical Therapy's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=16.615/154.801
=10.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


US Physical Therapy Operating Income Related Terms

Thank you for viewing the detailed overview of US Physical Therapy's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.


US Physical Therapy (US Physical Therapy) Business Description

Traded in Other Exchanges
Address
1300 West Sam Houston Parkway South, Suite 300, Houston, TX, USA, 77042
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal sources of payment for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Executives
Clayton Trier director 1300 WEST SAM HOUSTON PARKWAY SOUTH, SUITE 300, HOUSTON TX 77042
Kathleen A Gilmartin director 1300 W SAM HOUSTON PKWY S, SUITE 300, HOUSTON TX 77042
Nancy Ham director U.S. PHYSICAL THERAPY INC., 1300 W SAM HOUSTON PARKWAY - SUITE 100, HOUSTON TX 77042
Richard Binstein officer: EVP Gen'l Counsel & Secretary 3733 ROSEMONT PASS, NEWTOWN SQUARE PA 19037
Edward L Kuntz director
Graham D. Reeve officer: COO 1300 W. SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Harris Bernard A Jr director 3411 ERIN KNOLL CT, HOUSTON TX 77059
Carey P Hendrickson officer: Chief Financial Officer, other: Effective 11/9/2020 400 S. RECORD STREET, DALLAS TX 75202
Eric Joseph Williams officer: Chief Operations Officer 1300 SAM HOUSTON PARKWAY W, SUITE 300, HOUSTON TX 77042
Harry S Chapman director 4626 DRAKE FALLS COURT, KATY TX 77450
Christopher J Reading officer: Chief Operating Officer
Mark J Brookner director 1300 W SAM HOUSTON PARKWAY S, STE 300, HOUSTON TX 77042
Regg E. Swanson director, Director 1737 BURKE HOLLOW ROAD, NOLENSVILLE TN 37037
Anne Motsenbocker director 1300 W SAM HOUSTON PARKWAY, SUITE 300, HOUSTON TX 77042
Glenn Mcdowell officer: Chief Operating Officer 1300 W. SAM HOUSTON PKWY S., SUITE 300, HOUSTON TX 77042